Skip to main content
Top
Published in: Journal of Cancer Survivorship 5/2020

01-10-2020 | Coronavirus | Editorial

Addressing the needs of cancer survivors during the COVID-19 pandemic

Authors: Larissa Nekhlyudov, Saskia Duijts, Shawna V. Hudson, Jennifer M. Jones, Justin Keogh, Brad Love, Maryam Lustberg, Katherine Clegg Smith, Amye Tevaarwerk, Xinhua Yu, Michael Feuerstein

Published in: Journal of Cancer Survivorship | Issue 5/2020

Login to get access

Excerpt

The recent COVID-19 pandemic has affected the world and has the potential to disproportionately affect and disrupt the lives of cancer survivors, including those currently in treatment, those who have completed treatment, and those who are now living cancer-free. There are currently over 17 million cancer survivors in the USA [1] and millions more around the world [2, 3]. Much has been published over the past several decades about the late and long-term effects of cancer treatment, alongside both the challenges and potential solutions to help patients navigate the healthcare system in order to receive high-quality survivorship care [4, 5]. To date, a number of organizations have provided the cancer survivorship community (both patients and healthcare providers) recommendations pertaining to COVID-19 (Box 1). Unfortunately, at this time, there is limited evidence regarding the impact of COVID-19 on cancer survivors, particularly those who have completed treatment. As the pandemic continues to evolve and scientific evidence emerges, more directed recommendations and guidelines will follow. As editors of the Journal of Cancer Survivorship, the only international peer-reviewed publication dedicated to expanding and disseminating knowledge pertaining directly to this patient population, we wrote this commentary to describe how COVID-19 may impact the physical, psychosocial, and healthcare delivery concerns of cancer survivors. We hope that this information may be helpful in addressing the needs of cancer survivors at the present time and frame the issues that will warrant attention in the future.
Box 1
Selected COVID-19 resources for cancer survivors and healthcare providers
General non-cancer support
World Health Organization
Centers for Disease Control and Prevention
General cancer-related support
American Cancer Society
American Society of Clinical Oncology
American Society of Hematology
Children’s Oncology Group
European Society of Medical Oncology
National Coalition for Cancer Survivorship
National Marrow Donor Program/BeTheMatch
Selected guidance from non-cancer disease-based organizations
American College of Cardiology
American Diabetes Association
American Thoracic Society
Psychological and social support
Cancer Support Community
CancerCare
GW Cancer Center
Exercise support
American Society of Sports Medicine
Employment support
Career and Cancer
Communication about COVID-19
Center to Advance Palliative Care
Vital Talk
Note: Resources listed here are mainly those in the USA. We encourage the readers to seek guidance from their local, regional, and/or national sources. Further, given the fluidity of the pandemic, the links provided may also change
Literature
1.
go back to reference Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69:363–85.CrossRef Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69:363–85.CrossRef
4.
go back to reference Kline RM, Arora NK, Bradley CJ, Brauer ER, Graves DL, Lunsford NB, et al. Long-term survivorship care after cancer treatment—summary of a 2017 National Cancer Policy Forum workshop. J Natl Cancer Inst. 2018;110:1300–10.CrossRef Kline RM, Arora NK, Bradley CJ, Brauer ER, Graves DL, Lunsford NB, et al. Long-term survivorship care after cancer treatment—summary of a 2017 National Cancer Policy Forum workshop. J Natl Cancer Inst. 2018;110:1300–10.CrossRef
5.
go back to reference Nekhlyudov L, Mollica MA, Jacobsen PB, Mayer DK, Shulman LN, Geiger AM. Developing a quality of cancer survivorship care framework: implications for clinical care, research, and policy. J Natl Cancer Inst. 2019;111:1120–30.CrossRef Nekhlyudov L, Mollica MA, Jacobsen PB, Mayer DK, Shulman LN, Geiger AM. Developing a quality of cancer survivorship care framework: implications for clinical care, research, and policy. J Natl Cancer Inst. 2019;111:1120–30.CrossRef
7.
go back to reference Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21:335–7.CrossRef Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21:335–7.CrossRef
9.
go back to reference Reed SC, Bell JF, Miglioretti DL, Nekhlyudov L, Fairman N, Joseph JG. Fear of cancer recurrence and associations with mental health status and individual characteristics among cancer survivors: findings from a nationally representative sample. J Psychosoc Oncol. 2020;38:125–42.CrossRef Reed SC, Bell JF, Miglioretti DL, Nekhlyudov L, Fairman N, Joseph JG. Fear of cancer recurrence and associations with mental health status and individual characteristics among cancer survivors: findings from a nationally representative sample. J Psychosoc Oncol. 2020;38:125–42.CrossRef
10.
go back to reference Carrera PM, Kantarjian HM, Blinder VS. The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment. CA Cancer J Clin. 2018;68:153–65.CrossRef Carrera PM, Kantarjian HM, Blinder VS. The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment. CA Cancer J Clin. 2018;68:153–65.CrossRef
11.
go back to reference Aaronson NK, Mattioli V, Minton O, Weis J, Johansen C, Dalton SO, et al. Beyond treatment—psychosocial and behavioural issues in cancer survivorship research and practice. EJC Suppl. 2014;12:54–64.CrossRef Aaronson NK, Mattioli V, Minton O, Weis J, Johansen C, Dalton SO, et al. Beyond treatment—psychosocial and behavioural issues in cancer survivorship research and practice. EJC Suppl. 2014;12:54–64.CrossRef
14.
go back to reference Agboola SO, Ju W, Elfiky A, Kvedar JC, Jethwani K. The effect of technology-based interventions on pain, depression, and quality of life in patients with cancer: a systematic review of randomized controlled trials. J Med Internet Res. 2015;17:e65.CrossRef Agboola SO, Ju W, Elfiky A, Kvedar JC, Jethwani K. The effect of technology-based interventions on pain, depression, and quality of life in patients with cancer: a systematic review of randomized controlled trials. J Med Internet Res. 2015;17:e65.CrossRef
15.
go back to reference Harris J, Cheevers K, Armes J. The emerging role of digital health in monitoring and supporting people living with cancer and the consequences of its treatments. Curr Opin Support Palliat Care. 2018;12:268–75.CrossRef Harris J, Cheevers K, Armes J. The emerging role of digital health in monitoring and supporting people living with cancer and the consequences of its treatments. Curr Opin Support Palliat Care. 2018;12:268–75.CrossRef
16.
go back to reference Dorri S, Asadi F, Olfatbakhsh A, Kazemi A. A systematic review of electronic health (eHealth) interventions to improve physical activity in patients with breast cancer. Breast Cancer. 2020;27:25–46.CrossRef Dorri S, Asadi F, Olfatbakhsh A, Kazemi A. A systematic review of electronic health (eHealth) interventions to improve physical activity in patients with breast cancer. Breast Cancer. 2020;27:25–46.CrossRef
17.
go back to reference Haberlin C, O'Dwyer T, Mockler D, Moran J, O'Donnell DM, Broderick J. The use of eHealth to promote physical activity in cancer survivors: a systematic review. Support Care Cancer. 2018;26:3323–36.CrossRef Haberlin C, O'Dwyer T, Mockler D, Moran J, O'Donnell DM, Broderick J. The use of eHealth to promote physical activity in cancer survivors: a systematic review. Support Care Cancer. 2018;26:3323–36.CrossRef
19.
go back to reference van Egmond MP, Duijts SFA, Loyen A, Vermeulen SJ, van der Beek AJ, Anema JR. Barriers and facilitators for return to work in cancer survivors with job loss experience: a focus group study. Eur J Cancer Care (Engl). 2017;26. https://doi.org/10.1111/ecc.12420. van Egmond MP, Duijts SFA, Loyen A, Vermeulen SJ, van der Beek AJ, Anema JR. Barriers and facilitators for return to work in cancer survivors with job loss experience: a focus group study. Eur J Cancer Care (Engl). 2017;26. https://​doi.​org/​10.​1111/​ecc.​12420.
21.
go back to reference Garg S, Williams NL, Ip A, Dicker AP. Clinical integration of digital solutions in health care: an overview of the current landscape of digital technologies in cancer care. JCO Clin Cancer Inform. 2018;2:1–9.CrossRef Garg S, Williams NL, Ip A, Dicker AP. Clinical integration of digital solutions in health care: an overview of the current landscape of digital technologies in cancer care. JCO Clin Cancer Inform. 2018;2:1–9.CrossRef
22.
go back to reference Basch E, Deal AM, Kris MG, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34:557–65.CrossRef Basch E, Deal AM, Kris MG, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34:557–65.CrossRef
23.
go back to reference Denis F, Basch E, Septans AL, Bennouna J, Urban T, Dueck AC, et al. Two-year survival comparing web-based symptom monitoring vs routine surveillance following treatment for lung cancer. JAMA. 2019;321:306–7.CrossRef Denis F, Basch E, Septans AL, Bennouna J, Urban T, Dueck AC, et al. Two-year survival comparing web-based symptom monitoring vs routine surveillance following treatment for lung cancer. JAMA. 2019;321:306–7.CrossRef
25.
go back to reference Calvert MJ, O'Connor DJ, Basch EM. Harnessing the patient voice in real-world evidence: the essential role of patient-reported outcomes. Nat Rev Drug Discov. 2019;18:731–2.CrossRef Calvert MJ, O'Connor DJ, Basch EM. Harnessing the patient voice in real-world evidence: the essential role of patient-reported outcomes. Nat Rev Drug Discov. 2019;18:731–2.CrossRef
26.
go back to reference Butow P, Sharp L, Thewes B, Turner J, Gilchrist J, Beith J. Fear of cancer recurrence: a practical guide for clinicians. Oncology (Williston Park). 2018;32(1):32–8. Butow P, Sharp L, Thewes B, Turner J, Gilchrist J, Beith J. Fear of cancer recurrence: a practical guide for clinicians. Oncology (Williston Park). 2018;32(1):32–8.
27.
go back to reference Kent EE, Wheldon CW, Smith AW, Srinivasan S, Geiger AM. Care delivery, patient experiences, and health outcomes among sexual and gender minority patients with cancer and survivors: a scoping review. Cancer. 2019;125:4371–9.CrossRef Kent EE, Wheldon CW, Smith AW, Srinivasan S, Geiger AM. Care delivery, patient experiences, and health outcomes among sexual and gender minority patients with cancer and survivors: a scoping review. Cancer. 2019;125:4371–9.CrossRef
28.
go back to reference O'Malley DM, Tsui J, Davis SN, Hudson SV. Disparities. In: Feuerstein M, Nekhlyudov L, editors. Handbook of cancer survivorship. New York: Springer Science+Business Media; 2018. p. 73–89.CrossRef O'Malley DM, Tsui J, Davis SN, Hudson SV. Disparities. In: Feuerstein M, Nekhlyudov L, editors. Handbook of cancer survivorship. New York: Springer Science+Business Media; 2018. p. 73–89.CrossRef
Metadata
Title
Addressing the needs of cancer survivors during the COVID-19 pandemic
Authors
Larissa Nekhlyudov
Saskia Duijts
Shawna V. Hudson
Jennifer M. Jones
Justin Keogh
Brad Love
Maryam Lustberg
Katherine Clegg Smith
Amye Tevaarwerk
Xinhua Yu
Michael Feuerstein
Publication date
01-10-2020
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 5/2020
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-020-00884-w

Other articles of this Issue 5/2020

Journal of Cancer Survivorship 5/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine